|
ZNF793 expression based on
|
Statistics: Unpaired two sample T-test was employed to evaluate levels of significance in expression level between any two sample groups
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.55044898931101E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.45889997252391E-09 |
| Normal-vs-Stage2 |
2.15270000047951E-07 |
| Normal-vs-Stage3 |
7.2205019741034E-11 |
| Normal-vs-Stage4 |
3.20039994505805E-10 |
| Stage1-vs-Stage2 |
5.737400E-01 |
| Stage1-vs-Stage3 |
1.825700E-02 |
| Stage1-vs-Stage4 |
9.701100E-03 |
| Stage2-vs-Stage3 |
2.678200E-01 |
| Stage2-vs-Stage4 |
9.692500E-02 |
| Stage3-vs-Stage4 |
5.001200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.703803764741E-11 |
| Normal-vs-AfricanAmerican |
3.75940000000297E-05 |
| Normal-vs-Asian |
1.557810E-04 |
| Caucasian-vs-AfricanAmerican |
9.538200E-01 |
| Caucasian-vs-Asian |
6.628200E-02 |
| AfricanAmerican-vs-Asian |
1.928040E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.35639999957016E-07 |
| Normal-vs-Female |
1.93334237508225E-12 |
| Male-vs-Female |
3.741800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62379998336348E-09 |
| Normal-vs-Age(41-60Yrs) |
2.06800021551601E-10 |
| Normal-vs-Age(61-80Yrs) |
2.48400189306608E-11 |
| Normal-vs-Age(81-100Yrs) |
2.030600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.632800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.971900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.766600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.509800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.129600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.524200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.93790000005912E-07 |
| Classical-VS-Follicular |
9.389600E-01 |
| Classical-VS-Other |
5.705200E-01 |
| Classical-VS-Normal |
2.78539968867619E-10 |
| Tall-VS-Follicular |
3.69009999999781E-05 |
| Tall-VS-Other |
4.115800E-03 |
| Tall-VS-Normal |
2.8421709430404E-14 |
| Follicular-VS-Other |
6.482200E-01 |
| Follicular-VS-Normal |
1.4049000000016E-06 |
| Other-VS-Normal |
6.813600E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.76929999540221E-08 |
| Normal-vs-N1 |
4.08160000242574E-08 |
| N0-vs-N1 |
3.959000E-01 |
|
|
